Archive | October, 2009

In Search of Analgesia: Emerging Poles of GPCRs in Pain

Molecular Interventions American Society for Pharmacology and Experimental Therapeutics Mol Interv. Oct 2009; 9(5): 234–251. doi:  10.1124/mi.9.5.7 PMCID: PMC2861805 In Search of Analgesia: Emerging Poles of GPCRs in Pain Laura S. Stone1 and Derek C. Molliver2 Author information ► Copyright and License information ► This article has been cited by other articles in PMC. Go to: Short abstract Of all clinically marketed drugs, greater […]

Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis.

2009 Oct;57(13):1374-85. doi: 10.1002/glia.20856. Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis. Lorente M1, Carracedo A, Torres S, Natali F, Egia A, Hernández-Tiedra S, Salazar M, Blázquez C, Guzmán M, Velasco G. Author information Abstract Gliomas, one of the most malignant forms of cancer, exhibit high resistance to conventional therapies. Identification of the molecular mechanisms responsible for this resistance is […]

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities

Trends Pharmacol Sci. Author manuscript; available in PMC 2009 Oct 5. Published in final edited form as: Trends Pharmacol Sci. 2009 Aug; 30(8): 411–420.  Published online 2009 Jul 14. doi:  10.1016/j.tips.2009.05.004 PMCID: PMC2757311 NIHMSID: NIHMS145432 The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities Tamás Bíró,1 Balázs I. Tóth,1 György Haskó,2 Ralf Paus,3,4 and  Pál Pacher5 Author information ► Copyright […]